| abstract |
The invention relates to a method for treating a patient suffering from diabetes, which consists in administering to said patient a hybrid molecule containing a cytoxin covalently joined to interleukin 2, a molecule which is capable of binding to the receptor of l 'interleukin 2 on a cell contributing to the disease state and which is also capable of reducing the viability of this cell. |